Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

Wang, YF; Tai, WB; Yang, J; Zhao, GY; Sun, SH; Tseng, CTK; Jiang, SB; Zhou, YS; Du, LY; Gao, JM

Gao, JM (reprint author), Wenzhou Med Univ, Sch Med Lab Sci, Wenzhou 325035, Zhejiang, Peoples R China.; Du, LY (reprint author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017; 13 (7): 1615

Abstract

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS......

Full Text Link